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Abstract
Introduction The outlook of pediatric hydrocephalus has
spectacularly improved over the past decades; however,
the adult outcome is still poorly documented. Determining
the healthcare profile of these patients is important in order
to organize the management of this growing population. We
decided to review our pediatric hydrocephalus database for
pediatric patients treated for hydrocephalus and followed up
into adulthood.
Methods Our institution has a virtual monopoly for pediat-
ric hydrocephalus, serving a four-million-plus population;
the transition to adult care is also managed in the same
institution. We retrospectively reviewed patients younger
than 18 treated for hydrocephalus since 1980 and followed
up beyond the age of 20.
Results We reviewed 456 patients, with a mean initial age of
55.6 months, and followed up for a mean of 24.2 years. In
81 patients (17.8%), the last shunt operation occurred after
20 years; 22 of these (4.9% of the total) having never been
revised earlier. Sixteen patients (3.5%) could be weaned of
their shunt. Thirteen patients died in adult age, 5 of these
dying of shunt-related causes. The most prominent sequels
were motor (46.5%) and cognitive (47.6%); only 82 patients
(18.0%) had no sequel at all. Intelligence quotient values
were ≥80 in 54.5% of tested patients; however, schooling
was normal in only 41.4%, and only 33.7% was employed
in the competitive labor market.
Conclusion Adults treated for hydrocephalus in childhood
require a life-long follow-up. Late mortality is low but not
null, morbidity is high, and many patients require shunt
surgery during adulthood. The transition from child to adult
neurosurgery needs to be organized for these vulnerable
patients.
Keywords Pediatrichydrocephalus.Mortality.Shunt
obstruction.Child-to-adulttransition
Introduction
Historically, the outcome of hydrocephalus used to be appall-
ing: Laurence reported in 1962 a 20% survival rate into adult-
hood, the surviving patients having generally severe sequels
[17]. The outcome of hydrocephalic children has undergone a
sea change when shunts were introduced in the 1960s, with
most patients surviving the initial phase and growing into
adulthood. However, the long-term outcome of children trea-
ted for hydrocephalus is poorly documented because most
studies available were based on surveys, and thus subject to
important selection biases, and involving limited numbers of
patients [8, 19, 21, 22], or very detailed studies with a short
follow-up [16, 24]. In our hospital, we have organized a long
time ago a systematic follow-up of pediatric patients in the
adult neurosurgery clinic when they become adults.
Wedecidedtoreviewourclinicaldatabaseinordertostudy
the outcome of patients treated for hydrocephalus during
childhood and followed up beyond their 20th birthday.
Material and methods
Our hospital is the sole referral center for pediatric neuro-
surgery, serving a four-million population area. Our patients
have been logged prospectively in a database since the
1970s, which became computerized in the 1990s. The
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surgical clinics. Our policy it to follow-up patients every
second year for life, and systematic appointments are sent
from our secretariat; once the patients become adults
(around 20 years), the biannual neurosurgical follow-up is
continued in the adult neurosurgical clinic. Our policy is to
revise asymptomatic ruptured shunts whenever the patient is
considered shunt-dependent, which is attested by a previous
history of symptomatic shunt failure or a positive shunto-
gram (patent shunt) or badly tolerated ligation test [31].
We retrospectively selected cases of patients <18 years
operated for hydrocephalus between January 1980 and De-
cember 2007 and followed up beyond the age of 20. Reopera-
tions included all surgical procedures including test ligation
and removal; shunt infection was defined as a clinical diagno-
sis of infection, with or without positive culture, occurring any
time during the follow-up, leading either to shunt removal or
the patient’s demise; shunt failure was defined as shunt mal-
function or infection requiring reoperation or leading to the
patient’s demise. Functional outcome was evaluated quantita-
tively using the Karnofsky independence scale (1000asymp-
tomatic, 800able to assume normal life, 00dead) and the
Glasgow Outcome Score (GOS) according to the World Fed-
eration of Neurosurgical Societies (10normal life, 50dead)
and qualitatively by rating the different sequels as present or
absent. Intelligence quotient (IQ) evaluation was performed
using the WISC III test in patients selected on a case-by-case
basis;forthepurposeofthestudy, allresultsfor agiven patient
were averaged; normal IQ was defined as an average IQ at or
above 80. Schooling was rated as: normal curriculum; short-
ened curriculum in a normal school; schooling with aides (like
support during classes, additional time for exams, etc.); school
in specialized institution; and none at all. Social status at last
control was rated as: normal job (full employment in the
competitive labor market or autonomous mother-at-home);
unemployed (job seeker on the competitive labor market);
sheltered job (granted or in waiting); handicapped (living on
a pension at home or in a shelter); whenever the young adult
had not completed his learning curriculum (whichever it was),
the case was rated as “non-evaluable.”Theunemploymentrate
was defined as the ratio job seeker/(normal job + job seekers).
As the study was mostly retrospective, we used only
descriptive statistics and no tests; actuarial survival was
calculated using the Kaplan–Meier method, using the soft-
ware SPSS 15.0 for Windows.
Results
Constitution of the series
During the period of the study, 1,973 patients were followed
up for hydrocephalus; among these, 274 died before
reaching the age of 20 years and 1,243 were either under
20 or lost to follow-up at the time of the collection of data.
The remaining 456 patients represent the study group. These
patients were 236 male and 220 female, the median age at
first shunt implantation was 11.0 months (mean, 55.6; 95%
CI, 54.3–57.0); only 50 were more than 15 years old at the
time of initial treatment. The causes of hydrocephalus were
tumor in 125 (27.4%), spina bifida in 85 (18.6%), meningi-
tis in 59 (12.9%), hemorrhage in 57 (12.5%), arachnoid cyst
in 32 (7.0%), other cerebral malformations in 55 (12.1%),
traumatic in 15 (3.3%), Dandy–Walker syndrome in 6
(1.3%), other skeletal malformation in 5 (1.1%), and un-
known in 17 (3.7%). The initial treatments were ventriculo-
peritoneal shunt in 376 (82.5%), endoscopic procedure in 40
(8.8%), and other shunts in 40 (8.8%). The median follow-
up was 23.0 years (range, 20 to 44; mean, 24.2; 95% CI,
24.0–24.3).
Surgical outcome
During the period of follow-up, these 456 patients under-
went 1,226 reoperations (mean, 2.7 per patient). The surgi-
cal outcome after initial surgery is shown in Fig. 1, and the
number of reoperations per patient is detailed in Fig. 2.
Overall, 91 patients had not been reoperated yet at the last
control, 346 had at least one reoperation before reaching the
age of 20, and 81 (17.8% of the series) underwent at least
Fig. 1 Actuarial event-free survival after the first surgery. This curve
shows the characteristic biphasic curve initially, and then the curve
shows a shoulder around 15 years, becoming almost parallel to the
baseline. However, several patients had their first shunt revision after
20 years, showing that patients who have never been revised before
cannot be considered as shunt-independent
848 Childs Nerv Syst (2012) 28:847–854one reoperation after the age of 20; in 22 of these (4.9% of
the series), the first reoperation took place after the age of
20. Five patients in the series died of shunt-related causes
after the age of 20; in one of these, the diagnosis of shunt
failure was delayed in part because the shunt had never been
revised before. Over the whole series, the shunt-related
mortality rate could be established at 4.2% before the age
of 20 years and 7.2% at 30 years.
Shunt infection occurred 88 times in 71 patients (5.2%
per operation, 15.6% per patient); in 11 patients, shunt
infection occurred after the age of 20, leading to death in
one case. Procedures aimed at achieving shunt indepen-
dence were attempted in 27 cases: through shuntography
and/or ligature (15), endoscopy (7), or forced removal be-
cause of infection (5); this resulted in shunt independence in
16 and failure to achieve shunt independence in 11. Latex
allergy was recorded in 36 cases (7.9%), associated with
myelomeningocele in 25 cases (representing 29.4% of
patients with myelomeningocele).
Mortality
As mentioned earlier, mortality before 20 years affected 287
patients, making for an actuarial mortality rate of 18.1% at
20 years. Among survivors, 15 (2.85%) died after the age of
20 years, with 5 of these dying of shunt-related causes. The
last casualty was recorded at the age of 27 years; the actu-
arial overall mortality rate after 20 years was 6.3% (Fig. 3).
Functional outcome
Karnofsky independence scale ratings were available in 448
patients (98.2%); the results are detailed in Fig. 4; overall,
241 (53.7%) had a KNK score at or above 80, meaning
autonomous activity. The most common sequels were cog-
nitive in 217 (47.6%), motor in 212 (46.6%), epilepsy in
105 (23.0%), behavior disturbance in 69 (15.1%), endocrine
disorders in 66 (14.5%), vision loss in 62 (13.6%), pain in
35 (14.5%), and breathing problems in 12 (2.6%) cases. In
actuarial analysis, the cumulated incidence of secondary
epilepsy was 6.1% at 20 years and 13.1% at 30 years. Only
82 patients (18.0%) were immune to any of these ailments at
last control (Fig. 5). Pregnancy was recorded in 32 cases
(14.5% of female patients).
The functional outcome by cause of hydrocephalus is
detailed in Table 1; our data show a generally poorer out-
come for hydrocephalus diagnosed at birth (malformative,
posthemorrhagic, postmeningitis, and myelomeningocele),
compared with other causes like arachnoid cysts or tumoral
hydrocephalus. We also studied the overall outcome
Fig. 2 Number of reoperations per patient. Most patients had at least
one reoperation, although 91 (20.0%) had not required any reoperation
at last control
Fig. 3 Mortality after the age of 20. Thirteen patients died between 20
and 27 years, the actuarial mortality was 13%
Fig. 4 Distribution of Karnofsky independence score; 53.8% had a
KNK score at or above 80 (independent life)
Childs Nerv Syst (2012) 28:847–854 849(evaluated with the GOS) according to the year of initial
treatment, plotted in Fig. 6; this figure suggests that mortal-
ity and severe morbidity (GOS 3 to 5) were higher for
patients treated in the 1980s and early 1990s.
Social outcome
Schooling was documented in 446 cases (97.8%): 189
(41.4%) followed a normal, complete curriculum; 16
(3.3%) had a short curriculum in a normal school; 70
(15.4%) required some help at school; 145 (31.8%) required
schooling in special institutions; and 26 (5.7%) could not be
schooled at all.
Data on the patient’s social outcome were available in
452 patients (99.1%): 111 (24.6%) were still in the course of
their studies and were considered not evaluable; 115
(25.4%) had a normal job; 38 (8.4%) were job seekers; 80
(17.7%) were employed on sheltered jobs; and 108 (23.9%)
had no occupation. Among evaluable patients, 33.7% had a
normal job. Among employable patients (normal job + job
seekers), the unemployment rate was 24.8%; as a compari-
son, the unemployment rate for those under 25 years was
16.3% in 2008 (median of the last control in our study) [12].
In order to illustrate the discrepancy between neuropsycho-
logical testing, academic achievement, and social integra-
tion, we plotted these variables in Fig. 7.
Discussion
Methodology
Our series represents a large number of patients treated
during childhood for hydrocephalus and followed up into
adult age, based on a relatively stable population sample of
four million. Although the accrual of patients was prospec-
tive and consecutive, the collection of data for the present
study was for a large part retrospective. This leads to some
uncertainty, in particular over the real incidence of the
different types of sequels, leading to likely underestimation
of sequels, but also of the number of pregnant women. The
number of patients lost to follow-up is also a limitation:
some of them may have died; but more probably, the
patients who moved or interrupted follow-up were more
able than those who did not. Also, the retrospective evalu-
ation of many patients did not allow the use of more sophis-
ticated scores than the rather crude GOS (5 grades) or KNK
autonomy score (11 grades), and neuropsychological testing
was available for only a minority of patients. Finally, study-
ing the adult outcome of patients treated at birth amounts to
evaluating standards of care of two decades ago. However,
these limitations being acknowledged, we think that the
present series gives a more realistic view of the outlook of
hydrocephalic children than series based on voluntary par-
ticipation or filling a questionnaire [8, 21, 22]. Obviously,
having all patients filling prospectively a form dedicated to
hydrocephalus, like the Hydrocephalus Outcome Question-
naire (HOQ) [16, 24], is certainly the gold standard for this
type of studies, but this is a huge undertaking and some time
will pass before we can see the adult outcome. For the time
being, and with the aforementioned caveats, we think our
data can be useful.
Surgical outcome
Shunt malfunction is a permanent risk in patients treated
with shunts, carrying risks of both morbidity and mortality.
All studies of shunt outcome show similar biphasic survival
curves; however, the incidence of very late obstruction is
poorly documented in the literature. In a previous study, we
found that, after a typical biphasic curve, a shoulder could
be seen around 15 years, with a third segment close to the
zero line; however, several patients had presented very late
with their first shunt malfunction [33]. Our present study
confirms that many patients shunted during childhood re-
quire reoperation when they are adults, some of them for the
Fig. 5 Prevalence of the
different sequels among the
patients of the series. Only 82
patients (18.0%) were free of all
of these ailments
850 Childs Nerv Syst (2012) 28:847–854first time; it also shows that late malfunction in an unpre-
pared patient can be fatal. Regarding patients treated by
endoscopy, the incidence of obstruction is markedly lower
than with shunts; however, long-term data are even less
clear; whatsoever, it is now certain that delayed obstruction
of the stomy is a very serious threat as well [7].
Late shunt infection is a risk inherent in harboring a
shunt, and although surgery is the most common source of
infection, contamination sometimes comes from other sour-
ces. In a previous study, we found that the yearly incidence
of infections beyond the first postoperative year was 0.28%
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Fig. 6 Overall outcome. The outcome was evaluated with the GOS
(GOS 10normal life, GOS 50dead) according to the year of initial
treatment; this figure suggests that mortality and severe morbidity
(GOS 3 to 5) were higher for patients treated in the 1980s and early
1990s. However, patients treated in the 1990s must have been older
than the average at the time of initial treatment to meet the inclusion
criteria, and their follow-up was also shorter, introducing important
biases
Fig. 7 Comparison between IQ testing, schooling, and social integra-
tion. Normal IQ was defined as 80 or higher. The discrepancy points at
underestimation of handicap by formal testing and academic achieve-
ments, representing “the invisible handicap”
Childs Nerv Syst (2012) 28:847–854 851[30]. Among the sources of late shunt infection, abdominal
complications are prevalent; in particular, the yearly inci-
dence of bowel perforation by the peritoneal catheter was
estimated at 0.1%, affecting especially severely handi-
capped patients [32]. In the present study, shunt infection
occurred after the age of 20 in 11 cases and was fatal in 1
case. Patients and their caretakers should be given informa-
tion on this risk in order to organize prompt diagnosis and
treatment.
Evidence of shunt dependence is provided by the occur-
rence of symptomatic shunt failure. When a patient who has
never been revised before presents with an asymptomatic
shunt rupture, the question arises of either a ruptured but
still functional shunt or an obstructed shunt in a patient who
has become at some point shunt-independent. In any case, a
broken shunt in an asymptomatic patient should not be taken
as a proof of shunt independence, even with a wide gap
between the shunt fragments [6]. In our practice, the answer
to the question requires a shuntogram, catheter ligation if the
shuntogram shows no flow, then shunt removal if the liga-
ture is well tolerated. In the present series, following this
procedure resulted in shunt independence in only six cases;
in four cases, the test failed to achieve shunt independence.
Shunt independence can also be achieved through endosco-
py [5]; however, in our series, shunt independence was
achieved through endoscopy in only three of the seven
attempts. Overall, our experience confirms that, for shunted
patients, achieving shunt independence is exceptional; the
fact that 22 patients had their first shunt malfunction after
20 years is a reminder that the absence of shunt malfunction
does not mean that the shunt is useless. The old dictum
“once a shunt, always a shunt” admits very few exceptions.
Mortality
Few studies focus on the long-term mortality in pediatric
patients treated for hydrocephalus. The mortality rate ranges
between 13% after 17 years [19], 22% at 20 years [21], and
22% at 10 years [28], but series are often polluted by
intercurrent causes of mortality. Focusing on nontumoral
hydrocephalus, Tuli and Casey found similar figures
(12.6% and 11% mortality at 10 years, respectively) [4,
29]; by contrast, Paulsen found a shunt-related mortality
rate of only 2.9% after 20 years [21]. In our series, 6.3%
of patients who had survived their 20th birthday died during
their third decade, and shunt-related mortality represented
two fifth of these. Patients with myelomeningocele were
overrepresented in shunt-related mortality; as reported ear-
lier, the excess risk being likely related to the Chiari mal-
formation [29]. Unexpected death in a shunted patient
should be considered shunt-related unless proved otherwise
[13]. In a previous study, we noted that the only mean at our
disposal to prevent such catastrophic outcome was
systematic follow-up and revision of asymptomatic ruptured
shunts [31]. The periodicity and modalities of this follow-up
are open to debate and depend on the medical resources
available.
Functional outcome
Neurological sequels are mostly related to the cause of
hydrocephalus rather than hydrocephalus itself, but can also
result from the initial severity of hydrocephalus and epi-
sodes of acute shunt malfunction. The profile of handicap
differs markedly between the different groups, as shown in
our Table 1. Motor sequels affect up to 60% of patients [10],
and Platenkamp reported that 13% needed aides for walking
and 17% needed a wheelchair [24]. Visual sequels include
vision loss, oculomotor problems, visual field defects, and
visual-perceptive deficiencies, affecting up to 83% of
patients according to Andersson [1]; these result from optic
nerve atrophy and brainstem and cortical lesions mostly
caused by episodes of intracranial hypertension. In our
series, 13.6% of adults were recorded as having a significant
visual impairment. Endocrine sequels are also common in
hydrocephalic patients; in particular, disturbance of the
gonadostimulin axis; although precocious puberty is a com-
mon finding during childhood [25], its relation to hypotha-
lamic dysfunction and its predictive value for low fertility in
adult life are poorly documented. In the series published by
Gupta, only 26.2% of adult women answering the survey
reported having been pregnant [8], which may still be an
overestimate; conversely, our figure (14.5% of female
patients) may be an underestimation because of the retro-
spective bias and relatively young age of our patients. Low
fertility is also a reflection of the poor social life and isola-
tion of many of these patients [8]. Epilepsy is common in
hydrocephalic patients and is caused by the initial brain
disease as well as the insertion of the catheter, as attested
by the presence of epileptic foci on postoperative EEG [2].
Piatt found that the incidence of new-onset epilepsy was
around 2% per year [23]. In our series, we found similar
figures in the early years after surgery; however, new cases
of epilepsy became rare as the patients grew up. Epilepsy
has been correlated with a lower IQ [10] and has a negative
impact on quality of life measured by the HOQ [16]. Many
other ailments are underreported but have a major impact in
the quality of life, such as depression, with an incidence as
high as 43% [8], or chronic headache, present in up to 44%
of adults [27].
Social outcome
Schooling and social integration of hydrocephalic patients
are mostly conditioned by their cognitive sequels. These
result from congenital malformation or aggression or from
852 Childs Nerv Syst (2012) 28:847–854the severity of hydrocephalus and subsequent complica-
tions. The severity of initial brain damage is considered
the most important determinant of intellectual outcome
[26], and its impact is maximal in newborns: in neonatal
hydrocephalus, Persson found cognitive sequels in 23 of 48
patients and no sequels in only 4 of 48 [22]. Our results
(Table 1) confirm that patients treated early in infancy
(mostly with posthemorrhagic and postmeningitis hydro-
cephalus) or patients with widespread brain damage (post-
traumatic hydrocephalus) have a poorer intellectual outcome
than patients whose hydrocephalus develops later and who
have a more focal brain lesion (like tumors or arachnoid
cysts). Platenkamp reported normal schooling in 59%, spe-
cial education in 33%, and no schooling at all in 9% [24]. In
our series, the figures (special education in 31.8% and no
schooling at all in 5.7%) are similar; the additional catego-
ries “short curriculum” and “help at school needed” shed
also some light on the specific needs and final academic
achievement of these patients.
Generally,cognitivehandicapsbecomemoreevidentasthe
patients advance intheir schoolcurriculumandbecomeadults
[11].Inalargestudyon403patientstestedafterafollow-upof
20 years, Gupta et al. found that 56.3% were functioning
normally and 58.8% were fully independent adults [8]; how-
ever, this study was based on voluntary participation and
suffers a bias of selection. Results in consecutive series show
less favorable results: 40% of the patients evaluated by
Hoppe-Hirsch et al. had dropped out of normal school curric-
ulum [10]. Among 82 patients followed up beyond the age of
16, Kokkonen found a normal intellectual functioning in
45.8%, schooling was normal in 60%, but only 11% had a
normal job [15]. Paulsen et al. found it more meaningful to
select patients aged more than 20: 23% of their patients were
still studying, 33% were working in the competitive labor
market, 23% were on sheltered jobs, and 21% were “not in
contact with the labor market due to chronic illness” [21]. We
found a similar number of patients still studying (24.6%) and
not evaluable regarding social integration; however, our em-
ploymentrates,both onnormaland sheltered jobs(25.4%and
17.7%, respectively), were lower, which can reflect a less
favorable socioeconomic system, but also a cohort of patients
with a generally more severe illness. Our Fig. 7 illustrates that
handicaps are underestimated by formal testing, as well as by
school evaluations, and that only few patients pass the final
test: social integration in a competitive environment. The
highest functions of the brain, which are the most important
for social integration, are also the most elusive to testing.
Child-to-adult transition
There is more or less a consensus over the need to follow-up
patients with hydrocephalus during all their childhood. Rare
opinions are voiced, challenging the practice of systematic
follow-up of hydrocephalus as a misuse of strained neuro-
surgical resources and proposing to dismiss the patients to
pediatricians or general practitioners [14]. However, every
now and then, grim stories are published as stark reminders
that, without routine and apparently useless follow-up, ter-
rible drama can strike [3, 7]. Despite of this, opinions
diverge over what happens when the patients become adults,
and no guideline exists for the long-term follow-up. The
general view is that the follow-up has to be continued:
Casey advised follow-up clinics every second year until
the age of 16 [4]; Paulsen proposed a follow-up in adulthood
every 4 or 5 years [21]. However, we think that very long
intervals between clinics may lead many patients to abandon
follow-up altogether. In our experience, many patients are
anxious to continue the regular follow-up in neurosurgery,
and they grudgingly accept being transferred to an adult
colleague by the pediatric neurosurgeon.
Transition from child to adult care has been defined as “a
multidimensional, multidisciplinary process that addresses
not only the medical needs of adolescents as they move
from children’s services to adult services but also their
psychosocial, educational, and vocational needs” [20]. This
holistic definition sets very high standards, which are rarely
met. Regarding hydrocephalus, the patient’s health needs
are highly varied, according to the severity of sequels, and
our Table 1 shows a number of different profiles according
to the cause of hydrocephalus. Knowledge of these different
needs is useful in order to anticipate the process of transi-
tion. Patients who have no physical impairment need only a
neurosurgical follow-up. Some need to be persuaded to
continue this follow-up; conversely, others need to be en-
couraged to live a normal life and convinced that they
should not be forbidden any activity because of their shunt.
Generally, the follow-up of these patients has to tread a line
between too much fear and too much confidence. In these
purely neurosurgical patients, pediatric neurosurgeons have
a prominent role to play in managing the transition and
“apply their expertise to management of the adult patient”
[9]. This does not apply to patients with more severe mental
handicaps, who need daily care, or to patients with spina
bifida, who pose complex problems and are best managed
by rehabilitation specialists [33]. In any case, education of
the patient and his family requires collaboration, anticipa-
tion, and planning because transition is “a process, not an
event” [18].
Conclusions
Most children treated for hydrocephalus now reach adult
age; however, data on their outcome are still rare and con-
troversial. Our series, in spite of its biases, gives a picture of
what these patients have become and which problems they
Childs Nerv Syst (2012) 28:847–854 853face in adult life. These patients present with a wide spec-
trum of ailments, with an impact on autonomy ranging from
crippled to fully autonomous person. Our study also shows
that the incidence of shunt malfunction, potentially fatal,
becomes low but never null in adulthood. A life-long neu-
rosurgical follow-up of these patients must be organized and
adapted to the specific needs of each patient.
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